Lenalidomide Hydrate (5 mg/40 Capsules/1 case) 1 Set,and 13 other contracts

2026-11-03

Official in charge of disbursement of the procuring entity : Hitoshi Izu, Vice President, Tohoku University Classification of the products to be procured : Nature and quantity of the products to be purchased : A Lenalidomide Hydrate ( mg/4 Capsules/ case) Set B Satralizumab (Genetical Recombination) (12 mg/ ㎖/ vial) Set C Tisagenlecleucel Set D Axicabtagene ciloleucel Set E Idecabtagene vicleucel Set F Asfotase Alfa (Genetical Recombination) (4 mg/ ㎖/ vial) Set G Asfotase Alfa (Genetical Recombination) (8 mg/0. ㎖/ vial) Set H Onasemnogene abeparvove Set I Viltolarsen (25 mg/ ㎖/ vial) Set J Lisocabtagene maraleucel Set K Dinutuximab (Genetical Recombination) (17. mg/ ㎖/ vial) Set L Ravulizumab (Genetical Recombination) (30 mg/ ㎖/ vial) Set M Inebilizumab (Genetical Recombination) (10 mg/1 ㎖/ vials/ case) Set Delivery period : From April, 202 through 3 March, 202 Delivery place : Tohoku University Hospital Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall : A The same as the notice above No.107. B have the following Grade qualification, for each item in 5 above, ACDEFGHIJKLM have the Grade A, Grade B, or Grade C qualification during fiscal 202 in the Tohoku area in sales of product for participating in tenders by Single qualification for every ministry and agency, or in tenders by Tohoku University, B have the Grade A, Grade B, Grade C or Grade D qualification during fiscal 202 in the Tohoku area in sales of product for participating in tenders by Single qualification for every ministry and agency, or in tenders by Tohoku University, C prove to have obtained the wholesalers in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices, D The same as the notice above No.107. Deadline for submission of documents : 1 : 0 1 March, 202 The same as the notice above No.107. ⑼ The same as the notice above No.107.

Japan

2026-03-26